IART · Integra Lifesciences Holdings Corp · Webcasts, Transcripts & Audio
$14.40
+0.05 (+0.35%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.12B
Shares
77.80M
Volume · Nov 13
648.85K
Avg daily vol (3M)
1.02M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Integra Lifesciences Holdings Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Integra Lifesciences Holdings Corp (IART), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-21
Integra Lifesciences Holdings Corp (IART) Q3 2026 Earnings Call Transcript
Balanced tone
Tissue reconstruction recovery
Cincinnati manufacturing disruption
Neurosurgery momentum
Revenue
$411.18M
▲ 2.3% YoY Diluted EPS
$0.19
Gross margin
51.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Integra Lifesciences Holdings Corp (IART) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Integra Lifesciences Holdings Corp (IART) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
Integra Lifesciences Holdings Corp (IART) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
Integra Lifesciences Holdings Corp (IART) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-29
Integra Lifesciences Holdings Corp (IART) Q2 2026 Earnings Call Transcript
Positive tone
Surgimend/Durazorb relaunch and PMA strategy
Second quarter financial performance
Tissue reconstruction and wound care
Revenue
$418.76M
▲ 0.8% YoY Diluted EPS
$0.06
Gross margin
52.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
Integra Lifesciences Holdings Corp (IART) June 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Integra Lifesciences Holdings Corp (IART) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Integra Lifesciences Holdings Corp (IART) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Integra Lifesciences Holdings Corp (IART) Q1 2026 Earnings Call Transcript
Positive tone
Q1 Financial Results
CEO Transition and Leadership Change
Margins and Transformation
Revenue
$391.92M
▲ 2.4% YoY Diluted EPS
$-0.06
Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Integra Lifesciences Holdings Corp (IART) Q4 2025 Earnings Call Transcript
Positive tone
2026 financial guidance
Portfolio segment performance (CSS and Tissue)
International growth and China expansion
Revenue
$434.93M*
▼ 1.7% YoY Gross margin
50.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Transcript
Positive tone
Product relaunches (PriMatrix and Durepair)
Compliance Master Plan and FDA remediation
Supply chain and operational execution
Revenue
$402.06M
▲ 5.6% YoY Diluted EPS
$-0.07
Gross margin
51.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Integra Lifesciences Holdings Corp (IART) Q2 2025 Earnings Call Transcript
Positive tone
Revenue and EPS Guidance
Compliance Master Plan and Quality Remediation
Braintree Facility and Product Relaunch
Revenue
$415.61M
▼ 0.6% YoY Diluted EPS
$-6.31
Gross margin
50.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Transcript
Cautious tone
Tariffs and mitigation
Organic vs. reported revenue growth
Ship holds / supply disruption
Revenue
$382.65M
▲ 3.7% YoY Diluted EPS
$-0.33
Gross margin
50.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Transcript
Cautious tone
Manufacturing and Supply Chain Recovery
Portfolio Growth and Innovation
Compliance Master Plan and FDA Remediation
Revenue
$442.65M*
▲ 11.5% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Transcript
Cautious tone
Supply Constraints and Revenue Impact
2025 Guidance and Share Recapture
Quality and Compliance Master Plan
Revenue
$380.83M
▼ 0.4% YoY Diluted EPS
$-0.14
▼ 158.3% YoY Gross margin
52.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
Integra Lifesciences Holdings Corp (IART) Q2 2024 Earnings Call Transcript
Cautious tone
Compliance master plan and quality systems remediation
Acclarent integration and ENT franchise
Tissue Technologies portfolio strength
Revenue
$418.18M
▲ 9.7% YoY Diluted EPS
$-0.16
▼ 420% YoY Gross margin
54.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Integra Lifesciences Holdings Corp (IART) Q1 2024 Earnings Call Transcript
Cautious tone
Boston plant remediation and recall
Guidance and financial outlook
Acclarent acquisition and ENT expansion
Revenue
$368.87M
▼ 3.1% YoY Diluted EPS
$-0.04
▼ 113.8% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Integra Lifesciences Holdings Corp (IART) Q4 2023 Earnings Call Transcript
Balanced tone
Boston recall and manufacturing recovery
Financial results and 2024 guidance
International expansion and China strategy
Revenue
$397.04M*
▼ 0.2% YoY Gross margin
57.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Integra Lifesciences Holdings Corp (IART) Q3 2023 Earnings Call Transcript
Revenue
$382.42M
▼ 0.7% YoY Diluted EPS
$0.24
▼ 60% YoY Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Integra Lifesciences Holdings Corp (IART) Q2 2023 Earnings Call Transcript
Revenue
$381.27M
▼ 4.2% YoY Diluted EPS
$0.05
▼ 90.7% YoY Gross margin
54.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Integra Lifesciences Holdings Corp (IART) Q1 2023 Earnings Call Transcript
Revenue
$380.85M
▲ 1.1% YoY Diluted EPS
$0.29
▼ 25.6% YoY Gross margin
61.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-10
Integra Lifesciences Holdings Corp (IART) Q4 2022 Earnings Call Transcript
Revenue
$398.02M*
▼ 1.8% YoY Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Integra Lifesciences Holdings Corp (IART) Q3 2022 Earnings Call Transcript
Revenue
$385.19M
▼ 0.4% YoY Diluted EPS
$0.60
▲ 17.6% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Integra Lifesciences Holdings Corp (IART) Q2 2022 Earnings Call Transcript
Revenue
$397.81M
▲ 2% YoY Diluted EPS
$0.54
▲ 31.7% YoY Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Integra Lifesciences Holdings Corp (IART) Q1 2022 Earnings Call Transcript
Revenue
$376.64M
▲ 4.6% YoY Diluted EPS
$0.39
▼ 26.4% YoY Gross margin
62.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Integra Lifesciences Holdings Corp (IART) Q4 2021 Earnings Call Transcript
Revenue
$405.52M*
▲ 4.3% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Integra Lifesciences Holdings Corp (IART) Q3 2021 Earnings Call Transcript
Revenue
$386.86M
▲ 4.5% YoY Diluted EPS
$0.51
▲ 34.2% YoY Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Integra Lifesciences Holdings Corp (IART) Q2 2021 Earnings Call Transcript
Revenue
$389.99M
▲ 50.8% YoY Diluted EPS
$0.41
Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnings Call Transcript
Revenue
$360.07M
▲ 1.6% YoY Diluted EPS
$0.53
▲ 381.8% YoY Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-14
Integra Lifesciences Holdings Corp (IART) Q4 2020 Earnings Call Transcript
Revenue
$388.65M
▼ 1.6% YoY Diluted EPS
$1.09
▲ 505.6% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-06
Integra Lifesciences Holdings Corp (IART) Q3 2020 Earnings Call Transcript
Revenue
$370.23M
▼ 2.3% YoY Diluted EPS
$0.38
Gross margin
63.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-09
Integra Lifesciences Holdings Corp (IART) Q2 2020 Earnings Call Transcript
Revenue
$258.67M
▼ 32.6% YoY Diluted EPS
$0.00
▼ 100% YoY Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-07
Integra Lifesciences Holdings Corp (IART) Q1 2020 Earnings Call Transcript
Revenue
$354.32M
▼ 1.5% YoY Diluted EPS
$0.11
▼ 71.1% YoY Gross margin
62.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-14
Integra Lifesciences Holdings Corp (IART) Q4 2019 Earnings Call
Revenue
$395.13M
▲ 3.1% YoY Diluted EPS
$0.18
▼ 37.9% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–35 of 35 webcasts
Key facts
CIK
917520
CUSIP
457985208
13F (30d)
187 filings
166 filers
Visit website
Investor relations